Orchid Cellmark's Q2 Revenues Up 7 Percent | GenomeWeb

The article has been updated to include additional comments from the company's earnings conference call.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orchid Cellmark this morning reported a 7 percent revenue increase for the second quarter on the strength of its UK business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.